Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3013247	li-/s-alb	mg/g (mg/g)	1026	1101	0.00%
3013247	li-/s-alb	— (—)	55	56	100.00%	Distribution not available
3013247	li-/s-alb	mg/g______ (mg/g)	23	23	0.00%
3013247	s-alb	mg/g (mg/g)	7	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Demyelinating diseases of the central nervous system

275

42.27

307.65

1.0

5.16

6.45

mg/g

0.99

257

MS-disease / Multiple Sclerosis

236

49.88

307.65

1.0

5.16

6.08

mg/g

0.55

220

Other demyelinating diseases of the central nervous system

159

70.75

291.81

1.0

4.97

5.61

mg/g

0.58

150

Disturbances of skin sensation

253

280

9.18

207.51

1.1

5.60

6.77

mg/g

1.62

242

267

Neurological diseases

323

167

9.76

187.78

1.1

1.0

6.34

6.54

mg/g

0.13

311

162

Visual disturbances and blindness

269

475

5.70

144.08

1.1

6.98

6.86

mg/g

0.05

257

455

Visual disturbances

262

454

5.82

143.41

1.1

7.00

6.92

mg/g

0.03

251

434

Optic neuritis

29.26

132.74

1.1

1.0

4.90

5.46

mg/g

0.56

Autoimmune diseases related-to ILD

362

706

4.30

131.79

1.1

5.76

7.68

mg/g

4.18

340

684

Symptoms and signs involving the nervous and musculoskeletal systems

266

536

4.99

123.16

1.1

6.84

7.06

mg/g

0.17

250

516

Symptoms and signs involving the skin and subcutaneous tissue

305

688

4.21

112.32

1.1

5.84

7.07

mg/g

2.69

292

658

ILD medications: immunosuppressive drugs

282

571

4.50

111.55

1.1

6.57

7.44

mg/g

0.79

270

548

Autoimmune diseases excluding thyroid diseases

396

560

3.85

106.59

1.1

6.85

7.27

mg/g

0.31

373

541

Autoimmune diseases excluding thyroid diseases, strict definition

386

550

3.83

103.55

1.1

6.87

7.31

mg/g

0.33

363

531

Abnormal findings on diagnostic imaging of central nervous system

20.13

95.92

1.1

1.0

5.58

5.88

mg/g

0.23

Headache

260

516

3.91

81.70

1.1

1.0

6.97

6.71

mg/g

0.10

248

494

ILD medications

376

627

3.24

79.76

1.1

6.50

7.22

mg/g

0.71

358

602

Subjective visual disturbances

123

200

6.20

72.08

1.0

1.1

7.19

7.12

mg/g

0.01

117

195

Other neurological diseases

230

477

3.75

68.56

1.1

8.21

7.30

mg/g

0.39

221

454

Autoimmune diseases

337

560

3.06

64.18

1.1

6.51

7.27

mg/g

0.67

319

541

L04AA Selective immunosuppressants

122

227

5.42

62.18

1.0

1.1

5.22

7.26

mg/g

3.16

116

216

Symptoms and signs involving cognition, perception, emotional state and behaviour

302

701

2.89

57.20

1.1

6.65

6.97

mg/g

0.36

286

672

General symptoms and signs

311

535

2.92

54.65

1.1

1.0

7.29

6.76

mg/g

0.28

295

513

Malaise and fatigue

162

323

3.96

52.42

1.1

1.0

7.27

6.98

mg/g

0.19

154

310

Used for control exclusion in common control thyroid runs

301

528

2.88

51.91

1.1

6.72

7.35

mg/g

0.48

284

510

Other symptoms and signs involving the nervous and musculoskeletal systems

151

399

3.80

49.61

1.1

5.88

6.58

mg/g

0.79

142

383

Cerebrovascular diseases (FINNGEN)

129

203

4.48

46.68

1.1

7.44

6.88

mg/g

0.39

124

190

Other symptoms and signs involving cognitive functions and awareness

126

264

4.24

46.46

1.1

7.94

8.17

mg/g

0.11

120

252

L04AX Other immunosuppressants

193

625

3.10

46.11

1.1

7.18

6.89

mg/g

0.21

184

595

Second line medication for Crohn's disease

197

648

3.05

45.78

1.1

7.16

6.80

mg/g

0.28

188

616

Cerebrovascular diseases

176

368

3.32

42.70

1.1

7.59

8.04

mg/g

0.33

167

350

Pain in limb

259

625

2.64

41.25

1.1

6.89

6.60

mg/g

0.22

248

601

ILD medications: prednisolone, methylprednisolone, prednisone

271

607

2.49

36.95

1.1

6.95

7.29

mg/g

0.24

255

584

Mood disorders, excluding more controls

247

571

2.55

35.97

1.1

6.48

7.39

mg/g

1.18

238

548

Other soft tissue disorders, not elsewhere classified

274

644

2.42

35.75

1.1

6.65

6.96

mg/g

0.22

261

620

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

165

489

2.94

35.06

1.1

6.90

7.66

mg/g

0.72

159

466

Migraine

183

510

2.80

34.56

1.1

1.0

5.43

6.14

mg/g

0.99

172

489

Dizziness and giddiness

193

558

2.70

33.96

1.1

6.12

7.02

mg/g

1.29

180

533

STROKE

156

342

3.08

33.34

1.1

7.63

7.48

mg/g

0.09

147

328

Stroke, including SAH

134

288

3.35

33.34

1.1

7.89

8.47

mg/g

0.37

128

274

Stroke, excluding SAH

126

265

3.44

32.74

1.1

7.79

8.55

mg/g

0.50

120

252

Ischaemic Stroke, excluding all haemorrhages

115

236

3.59

32.08

1.1

7.66

8.52

mg/g

0.58

109

223

Mood [affective] disorders

270

768

2.26

31.13

1.1

6.27

7.47

mg/g

1.72

261

733

Mood disorders

270

768

2.25

31.00

1.1

6.27

7.47

mg/g

1.72

261

733

Depression

258

762

2.27

30.47

1.1

6.24

7.42

mg/g

1.64

250

727

Anxiety disorders, excluding more controls

217

565

2.46

30.24

1.1

6.30

7.38

mg/g

1.48

204

541

Meningitis

9.83

27.69

1.1

1.0

14.95

7.80

mg/g

1.78

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

233

695

2.27

27.61

1.1

7.31

6.69

mg/g

0.57

221

667

Implicit Sepsis, including avohilmo

205

618

2.37

27.36

1.1

7.35

6.84

mg/g

0.42

196

592

Other headache syndromes

129

449

2.87

27.23

1.1

7.20

6.40

mg/g

0.59

122

431

Diseases of the eye and adnexa

213

439

2.44

27.16

1.1

5.70

7.11

mg/g

2.52

204

421

Anxiety disorders

243

764

2.19

26.55

1.1

6.19

7.38

mg/g

1.63

229

734

Condition for Implicit Sepsis (Organ dysfunction codes)

210

635

2.29

25.82

1.1

7.40

6.87

mg/g

0.43

201

608

Migraine with aura

303

3.25

25.58

1.1

1.0

5.09

5.60

mg/g

0.79

294

Neurotic, stress-related and somatoform disorders

240

766

2.16

25.58

1.1

6.20

7.37

mg/g

1.59

226

737

Anxiety (asthma-related co-morbidities)

192

624

2.34

25.33

1.1

5.67

7.39

mg/g

2.68

186

592

Episodal and paroxysmal disorders

263

625

2.14

25.17

1.1

6.28

7.14

mg/g

0.85

249

600

Cerebral cysts

7.54

24.63

1.0

13.69

6.30

mg/g

0.66

All anxiety disorders

199

683

2.27

24.44

1.1

5.59

7.13

mg/g

2.53

193

655

Implicit viral Sepsis, including avohilmo

237

3.46

23.76

1.2

1.1

9.17

7.09

mg/g

0.95

228

Pain in joint

146

338

2.66

23.65

1.1

1.0

6.67

6.77

mg/g

0.06

139

325

Disorders of ocular muscles, binocular movement, accommodation and refraction

153

623

2.44

23.41

1.0

1.1

6.97

6.53

mg/g

0.12

146

593

Extrapyramidal and movement disorders

281

3.21

23.17

1.2

1.0

6.11

7.71

mg/g

1.68

267

First line medication for Crohn's disease

272

725

2.02

22.99

1.1

1.0

8.04

6.43

mg/g

1.03

260

694

Other anxiety disorders

160

570

2.39

22.76

1.1

5.67

6.92

mg/g

1.48

152

546

Epilepsy

279

3.19

22.64

1.1

1.0

7.12

6.76

mg/g

0.19

270

Any mental disorder

238

575

2.08

21.20

1.1

6.02

7.37

mg/g

2.31

227

550

Special screening examination for infectious and parasitic diseases

101

251

2.95

20.73

1.1

6.69

5.91

mg/g

0.72

240

Guillain-Barre syndrome

31.28

20.71

1.3

1.0

18.91

6.49

mg/g

—

Syncope and collapse

260

2.99

20.38

1.1

1.0

6.41

7.49

mg/g

0.90

252

Papilloedema, unspecified

22.16

19.58

1.2

1.0

14.60

5.83

mg/g

0.62

Implicit Sepsis

164

562

2.15

17.78

1.1

7.42

6.97

mg/g

0.29

157

539

Migraine without aura

269

2.95

17.67

1.1

1.0

6.05

5.46

mg/g

0.33

261

Tramadol

178

506

2.12

17.65

1.2

1.0

7.03

6.75

mg/g

0.20

168

482

Depression or dysthymia

141

329

2.34

17.27

1.1

6.39

7.24

mg/g

0.78

134

314

Dorsalgia

233

645

1.92

17.10

1.1

6.69

6.82

mg/g

0.09

219

618

Examination and observation for other reasons

138

334

2.33

16.93

1.1

7.05

6.35

mg/g

0.58

132

322

Nerve, nerve root and plexus disorders

234

746

1.89

16.90

1.1

7.26

6.81

mg/g

0.35

219

719

Inflammatory bowel disease treatment related agents

261

793

1.83

16.79

1.1

7.07

6.97

mg/g

0.07

247

760

Symptoms and signs involving speech and voice

276

2.83

16.30

1.1

6.86

7.17

mg/g

0.18

262

Persons encountering health services for other counselling and medical advice, not elsewhere classified

241

691

1.85

16.10

1.1

7.08

7.26

mg/g

0.11

232

661

Small fibre neuropathy

18.82

16.04

1.0

8.33

7.57

mg/g

0.21

Soft tissue disorders

235

646

1.87

15.83

1.1

6.60

6.96

mg/g

0.27

222

622

Opioids

221

603

1.89

15.64

1.1

6.24

6.96

mg/g

0.72

211

574

Other dorsopathies, not elsewhere classified

231

648

1.85

15.34

1.1

6.62

6.81

mg/g

0.13

219

621

Oral corticosteroids

232

749

1.82

14.95

1.1

7.17

7.09

mg/g

0.05

218

719

Other antidepressants

212

574

1.89

14.82

1.1

6.43

7.43

mg/g

1.03

203

546

Myalgia

231

2.91

14.73

1.1

5.44

6.01

mg/g

0.47

222

Cystitis

182

554

1.96

14.68

1.1

7.04

6.53

mg/g

0.39

173

533

Certain infectious and parasitic diseases

213

569

1.88

14.59

1.1

1.0

6.88

6.49

mg/g

0.25

201

546

Codeine

206

593

1.88

14.45

1.1

6.47

6.86

mg/g

0.30

199

565

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

223

805

1.78

13.70

1.1

6.37

7.25

mg/g

1.02

215

767

Fever of other and unknown origin

110

428

2.23

13.59

1.1

1.0

9.40

6.83

mg/g

1.55

105

408

Persons encountering health services in other circumstances, wide

237

691

1.76

13.49

1.1

7.13

7.26

mg/g

0.08

227

661

Systemic connective tissue disorders

300

2.57

13.44

1.1

7.61

6.97

mg/g

0.26

286

Medical observation and evaluation for suspected diseases and conditions

139

336

2.12

13.33

1.1

6.64

6.34

mg/g

0.17

134

324

Exposure to unspecified factor

224

879

1.73

12.84

1.1

7.03

7.04

mg/g

0.00

215

840

Psychiatric diseases

191

518

1.85

12.58

1.1

6.30

7.30

mg/g

1.17

184

492

Dorsopathies

226

655

1.75

12.49

1.1

6.53

6.83

mg/g

0.21

213

628

Other diseases of urinary system

205

648

1.78

12.27

1.1

7.27

6.63

mg/g

0.48

193

624

Sixth [abducent] nerve palsy

13.52

11.95

1.1

1.0

5.73

6.46

mg/g

0.36

Intestinal infectious diseases, including avohilmo, including avohilmo

240

795

1.68

11.87

1.1

6.48

7.22

mg/g

0.75

232

757

Low back pain

169

620

1.84

11.85

1.1

6.58

6.43

mg/g

0.10

162

593

Disorders of lacrimal system

426

2.20

11.69

1.1

1.0

6.62

6.72

mg/g

0.05

405

Cerebral arteritis

+∞

11.68

1.9

0.0

9.18

—

mg/g

—

Paraplegia, diplegia of upper limbs

19.24

11.62

1.2

1.0

14.04

7.00

mg/g

—

Asthma, excluding more controls

163

446

1.88

11.39

1.1

7.33

6.74

mg/g

0.42

153

432

Use of dimethyl fumarate

20.94

11.24

1.0

6.66

5.58

mg/g

—

Asthma

164

455

1.86

11.17

1.1

7.34

6.75

mg/g

0.43

154

441

Other disorders of urethra and urinary system

142

520

1.90

11.09

1.1

1.0

7.16

6.52

mg/g

0.34

131

500

Pain (limb, back, neck, head abdominally)

136

344

1.98

11.05

1.1

1.0

6.81

6.68

mg/g

0.07

130

330

Dysphagia

192

2.77

10.75

1.1

1.0

8.38

7.99

mg/g

0.11

185

Selective serotonin reuptake inhibitors

193

583

1.72

10.30

1.1

6.80

7.40

mg/g

0.45

185

555

Organic, including symptomatic, mental disorders

202

2.44

10.23

1.2

1.1

8.03

9.09

mg/g

0.57

195

Other diseases of spinal cord

12.30

9.86

1.0

5.87

6.46

mg/g

0.24

Codeine or tramadol medication

228

766

1.62

9.76

1.1

6.57

7.11

mg/g

0.54

218

731

Asthma (mode)

157

459

1.80

9.74

1.1

7.29

6.75

mg/g

0.36

147

445

Lower back pain or/and sciatica

219

842

1.62

9.65

1.1

6.84

7.14

mg/g

0.22

209

805

Symptoms and signs involving the urinary system

142

598

1.79

9.45

1.1

8.30

6.91

mg/g

1.07

134

574

Metabolic disorders

189

679

1.67

9.39

1.1

7.94

6.81

mg/g

0.98

181

646

Disorders of optic nerve, not elsewhere classified

21.99

9.37

1.2

1.0

6.74

7.19

mg/g

—

Other reaction to severe stress, and adjustment disorders

497

1.97

9.22

1.1

6.12

6.09

mg/g

0.01

476

Viral hepatitis, IBD co-morbidity

13.70

9.17

1.1

1.0

4.59

4.52

mg/g

0.04

GASTRO-related operations

174

510

1.71

9.10

1.1

6.19

6.77

mg/g

0.43

166

492

Any gastric operation

174

510

1.71

9.10

1.1

6.19

6.77

mg/g

0.43

166

492

General examination and investigation of persons without complaint and reported diagnosis

123

336

1.90

9.08

1.1

6.40

6.34

mg/g

0.04

118

324

Persons encountering health services for specific procedures, not carried out

3.39

8.61

1.2

1.0

7.12

6.55

mg/g

0.16

Benign intracranial hypertension

16.70

8.60

1.0

23.29

4.99

mg/g

—

Follow-up examination after treatment for conditions other than malignant neoplasms

301

2.02

8.43

1.1

6.02

6.31

mg/g

0.19

289

Exposure to other specified factors

174

918

1.63

8.42

1.1

7.07

7.00

mg/g

0.04

169

875

Other systemic involvement of connective tissue

218

2.44

8.42

1.0

1.1

7.60

6.78

mg/g

0.25

211

Abnormalities of breathing

190

673

1.62

8.29

1.1

6.23

7.08

mg/g

1.10

180

645

Other systemic involvement of connective tissue (FG)

206

2.43

8.08

1.0

1.1

7.69

7.12

mg/g

0.15

199

Other specific joint derangements/joint disorders

172

660

1.63

7.84

1.1

6.44

7.05

mg/g

0.48

163

637

Disorders of eyelid, lacrimal system and orbit

166

748

1.63

7.84

1.2

1.1

6.89

6.83

mg/g

0.04

160

712

Other meningitis

10.97

7.82

1.2

1.0

14.18

5.34

mg/g

1.00

Diseases of inner ear

450

1.92

7.78

1.0

1.1

6.27

7.37

mg/g

1.01

429

Use of fingolimod

15.47

7.77

1.1

1.0

4.53

6.21

mg/g

—

Disorders of vestibular function (Vertigo)

392

1.99

7.75

1.1

6.35

7.52

mg/g

0.96

373

Certain infectious and parasitic diseases, including avohilmo

130

369

1.77

7.64

1.1

1.0

7.38

6.63

mg/g

0.38

122

354

Symptoms and signs involving the circulatory and respiratory systems

210

678

1.55

7.59

1.1

6.78

7.08

mg/g

0.11

202

650

Urinary track infection

135

389

1.74

7.55

1.1

1.0

5.73

5.50

mg/g

0.18

128

373

SLE (Finngen)

10.09

7.53

1.1

1.0

8.50

7.31

mg/g

0.20

Disorders of lipoprotein metabolism and other lipidaemias

136

483

1.71

7.53

1.0

1.1

7.81

7.41

mg/g

0.28

129

461

Infections with a predominantly sexual mode of transmission, including avohilmo

112

584

1.76

7.33

1.1

6.40

6.26

mg/g

0.07

106

555

Pain in throat and chest

175

651

1.59

7.31

1.0

1.1

7.15

7.07

mg/g

0.02

167

627

Asthma (only as main-diagnosis)

138

455

1.70

7.27

1.1

7.40

6.75

mg/g

0.39

131

441

Myasthenia gravis

15.95

7.25

1.0

6.60

7.02

mg/g

—

Asthma (only as main-diagnosis), excluding more controls

137

446

1.70

7.24

1.1

7.43

6.74

mg/g

0.42

130

432

Other disorders of bladder

3.83

7.24

1.1

1.0

7.09

9.48

mg/g

0.74

Bacterial meningitis

6.61

7.12

1.1

1.0

18.71

7.16

mg/g

2.02

Hard cardiovascular diseases

146

522

1.65

7.09

1.1

7.41

7.37

mg/g

0.02

137

501

Chronic sinusitis

502

1.83

7.04

1.1

6.62

6.79

mg/g

0.10

476

Infections with a predominantly sexual mode of transmission

461

1.87

6.95

1.2

1.1

6.86

5.85

mg/g

0.56

439

Other special examinations and investigations of persons without complaint or reported diagnosis

117

336

1.77

6.93

1.0

1.1

5.88

6.34

mg/g

0.37

110

324

Diseases of the musculoskeletal system and connective tissue

121

349

1.74

6.82

1.1

6.14

6.84

mg/g

0.37

116

339

Cardiovascular diseases (excluding rheumatic etc)

164

593

1.58

6.69

1.1

6.04

6.41

mg/g

0.22

159

566

Asthma, unspecified (mode)

102

415

1.78

6.68

1.0

1.1

6.72

6.82

mg/g

0.06

401

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

180

918

1.53

6.64

1.1

7.88

6.86

mg/g

0.73

172

878

Asthma, unspecified (mode), excluding more controls

101

407

1.78

6.63

1.0

1.1

6.65

6.81

mg/g

0.09

393

Caries of enamel

195

850

1.50

6.47

1.1

7.24

7.00

mg/g

0.07

182

816

Nontraumatic intracranial haemmorrhage

3.06

6.44

1.1

1.0

9.09

9.02

mg/g

0.02

Pure hypercholesterolaemia

113

419

1.71

6.40

1.0

1.1

8.07

7.60

mg/g

0.28

107

400

Bacterial Sepsis

269

2.00

6.28

1.2

1.1

10.84

8.02

mg/g

1.06

257

Mycoses, including avohilmo

180

909

1.51

6.27

1.1

7.44

6.98

mg/g

0.29

169

873

Symptoms and signs concerning food and fluid intake

3.51

6.13

1.2

1.0

9.43

7.49

mg/g

0.32

Neuralgia and neuritis, unspecified

5.18

6.01

1.2

1.1

11.25

8.01

mg/g

0.30

Other intervertebral disc disorders

145

548

1.58

5.95

1.1

7.54

6.63

mg/g

0.65

137

525

Triptan medication for migraine, min. 3 purchases

139

660

1.58

5.90

1.1

6.20

5.97

mg/g

0.15

133

628

Systemic lupus erythematosus

6.41

5.86

1.1

1.0

8.50

5.96

mg/g

0.58

COPD differential diagnosis

145

459

1.58

5.82

1.1

6.16

6.75

mg/g

0.67

136

445

ILD differential diagnosis

145

459

1.58

5.82

1.1

6.16

6.75

mg/g

0.67

136

445

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

184

837

1.48

5.82

1.1

7.23

6.76

mg/g

0.35

177

801

Dyspnoea

163

779

1.51

5.73

1.1

5.98

6.94

mg/g

1.63

154

745

Conjunctivitis (acute, non atopic), including avohilmo

187

765

1.48

5.70

1.1

6.72

7.46

mg/g

0.63

174

735

Hyperkinetic disorders, excluding more controls

169

2.27

5.61

1.0

1.1

4.88

5.81

mg/g

0.81

164

Postviral fatigue syndrome

13.15

5.61

1.0

4.45

5.43

mg/g

—

Hypothyroidism, strict autoimmune

108

428

1.66

5.52

1.1

5.89

6.79

mg/g

0.96

102

414

Diabetes insipidus

16.31

5.43

1.0

5.99

6.66

mg/g

—

Fall on same level

223

838

1.42

5.41

1.1

7.26

6.81

mg/g

0.35

212

802

Asthma (diagnoses ohter than nonallergic)

166

907

1.48

5.39

1.1

7.16

6.95

mg/g

0.12

157

868

SLE, strict definition

6.24

5.39

1.1

1.0

7.77

6.04

mg/g

0.35

SLE, ICD10

6.24

5.39

1.1

1.0

7.77

6.04

mg/g

0.35

Injuries to the wrist and hand

194

892

1.44

5.37

1.1

6.81

7.05

mg/g

0.16

185

853

Benzodiazepine use

186

866

1.45

5.31

1.1

6.51

7.18

mg/g

0.61

181

825

Sciatica+with lumbago

497

1.68

5.30

1.1

6.89

6.76

mg/g

0.07

475

Use of hypnotics and sedatives

194

767

1.45

5.30

1.1

7.01

6.90

mg/g

0.08

185

734

Excluding asthma or asthma-COPD overlap

142

459

1.55

5.26

1.1

6.13

6.76

mg/g

0.71

133

445

Immunodeficiency with predominantly antibody defects

6.73

5.26

1.3

1.0

5.88

5.66

mg/g

0.08

Other and unspecified effects of external causes

366

1.83

5.25

1.1

5.69

6.38

mg/g

0.60

353

Symptoms and signs involving the digestive system and abdomen

177

604

1.47

5.12

1.1

6.56

6.93

mg/g

0.29

168

581

All influenza

250

2.00

5.10

1.1

7.70

6.75

mg/g

0.41

242

Cauda equina syndrome

10.15

5.04

1.0

11.30

6.16

mg/g

—

Other disorders of optic disc

10.14

5.04

1.0

6.10

5.86

mg/g

—

Voice disturbances

231

2.04

5.03

1.1

1.0

6.31

7.40

mg/g

0.70

220

Intestinal infectious diseases

177

913

1.44

5.01

1.1

6.79

7.10

mg/g

0.21

169

873

Bacterial infection, other or unspecified

381

1.73

4.92

1.1

1.0

10.71

7.21

mg/g

1.66

367

Cluster headache, strict

6.04

4.91

1.0

6.33

6.26

mg/g

0.02

Cluster headache, wide

6.03

4.91

1.0

6.33

6.26

mg/g

0.02

Other pulmonary diagnosis

140

459

1.53

4.91

1.1

6.25

6.76

mg/g

0.45

131

445

Asthma-related infections

112

702

1.56

4.80

1.1

6.78

6.64

mg/g

0.08

105

671

Asthma, hospital admission 2, infections

112

702

1.56

4.80

1.1

6.78

6.64

mg/g

0.08

105

671

Other disorders of central nervous system

11.59

4.80

1.3

1.0

5.03

5.61

mg/g

—

Dissociative [conversion] disorders

3.59

4.77

1.0

4.50

5.28

mg/g

0.66

Other congenital malformations of circulatory system

5.77

4.76

1.1

1.0

6.31

5.97

mg/g

0.11

Persistent mood disorders

170

2.18

4.73

1.1

5.62

7.59

mg/g

2.08

162

Lumbar disc prolapse

110

520

1.57

4.67

1.1

8.01

6.77

mg/g

0.74

105

497

Cluster headache, strict, including avohilmo

3.51

4.61

1.1

1.0

6.22

6.82

mg/g

0.18

Fasciculation

14.18

4.59

1.0

5.57

5.87

mg/g

—

Nystagmus and other irregular eye movements

8.29

4.57

1.0

4.96

5.10

mg/g

—

Abdominal and pelvic pain

173

604

1.44

4.55

1.1

6.72

6.93

mg/g

0.14

167

581

Acute upper respiratory infections

182

772

1.41

4.51

1.0

1.1

6.28

7.23

mg/g

1.00

168

744

Complications of medical and surgical care

126

757

1.50

4.48

1.1

6.85

6.91

mg/g

0.04

120

722

Nephropathy related operations

2.65

4.48

1.2

1.0

11.33

8.99

mg/g

0.51

Persons encountering health services for specific procedures and health care

202

862

1.38

4.42

1.1

7.63

6.82

mg/g

0.60

195

822

Injuries to the knee and lower leg

217

856

1.37

4.41

1.1

7.83

6.78

mg/g

0.93

210

815

582

1.59

4.38

1.1

6.92

6.52

mg/g

0.21

553

Persons encountering health services for examination and investigation

106

336

1.58

4.37

1.1

6.67

6.34

mg/g

0.18

101

324

Other specified/unspecified hearing loss

3.10

4.35

1.1

1.0

5.42

9.69

mg/g

2.63

Dermatitis

112

722

1.52

4.33

1.1

7.20

6.92

mg/g

0.12

107

688

Cluster headache, wide,, including avohilmo

3.35

4.32

1.1

1.0

6.22

7.42

mg/g

0.39

Other and unspecified immunodeficiencies with predominantly antibody defects

11.82

4.29

1.0

4.80

4.55

mg/g

—

Other specified/unspecified necrotizing vasculopathies

11.80

4.28

1.3

1.0

9.07

6.13

mg/g

—

Other degenerative diseases of the basal ganglia

11.77

4.28

1.0

7.94

7.95

mg/g

—

Other and unspecified dermatitis

600

1.57

4.23

1.1

7.38

6.81

mg/g

0.22

572

Autonomic disorders

6.97

4.17

1.2

1.0

9.29

5.71

mg/g

—

Asthma, including avohilmo

213

863

1.36

4.16

1.1

6.88

7.08

mg/g

0.14

201

827

Emergency coronary revascularization (for ACS)

532

0.56

4.08

1.1

8.18

7.67

mg/g

0.16

510

Care involving use of rehabilitation procedures

112

672

1.50

4.07

1.2

1.1

6.97

6.73

mg/g

0.14

106

639

Acute upper respiratory infections of multiple and unspecified sites

146

744

1.43

4.07

1.0

1.1

5.68

7.15

mg/g

2.27

135

716

Coronary revascularization (ANGIO or CABG)

511

0.55

4.07

1.1

8.10

7.71

mg/g

0.11

489

Diarrhoea and gastroenteritis of presumed infectious origin

134

828

1.45

4.05

1.1

6.37

6.95

mg/g

0.53

127

791

Dermatitis and eczema

201

874

1.36

4.04

1.1

6.77

7.15

mg/g

0.26

193

835

Other diseases of intestines

202

826

1.36

4.03

1.1

6.72

6.89

mg/g

0.10

190

791

Percutaneous Coronary Intervention

510

0.55

4.03

1.1

8.10

7.71

mg/g

0.11

488

Acute sinusitis

110

668

1.50

3.99

1.0

1.1

6.24

7.06

mg/g

0.76

104

642

Dialysis, with operation codes

2.53

3.95

1.2

1.0

11.43

9.06

mg/g

0.50

Influenza and pneumonia

196

890

1.36

3.93

1.1

7.78

6.76

mg/g

0.88

183

856

Conjunctivitis

153

878

1.40

3.89

1.1

6.06

6.91

mg/g

0.97

147

837

Insomnia

166

835

1.38

3.81

1.1

6.48

7.05

mg/g

0.40

161

795

Disorders of vitreous body

378

1.66

3.77

1.1

7.28

7.84

mg/g

0.34

359

Circumscribed brain atrophy

12.07

3.77

1.0

8.90

8.23

mg/g

—

Herpesviral [herpes simplex] infections, including avohilmo

325

1.73

3.71

1.2

1.1

7.04

6.17

mg/g

0.39

310

Injuries to the ankle and foot

147

899

1.40

3.70

1.0

1.1

7.35

6.76

mg/g

0.39

139

861

Acute bronchitis

431

1.62

3.68

1.1

6.08

6.66

mg/g

0.54

417

157

659

1.39

3.65

1.1

7.58

7.09

mg/g

0.28

147

636

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

157

659

1.39

3.65

1.1

7.58

7.09

mg/g

0.28

147

636

Dental pulpitis, including avohilmo

177

833

1.36

3.64

1.1

6.28

7.11

mg/g

0.88

163

803

Behavioural syndromes associated with physiological disturbances and physical factors

171

847

1.37

3.64

1.1

6.74

7.13

mg/g

0.24

166

808

Obsessive-compulsive disorder

2.48

3.62

1.0

5.46

5.94

mg/g

0.25

Falls/tendency to fall

197

733

1.35

3.62

1.1

6.83

6.57

mg/g

0.17

187

701

Other specified and unspecified strabismus

7.87

3.57

1.3

1.0

4.00

9.61

mg/g

—

Benign neoplasm: Rectum, anus and anal canal

112

2.24

3.47

1.1

8.01

8.75

mg/g

0.23

104

Other joint disorders

174

668

1.36

3.44

1.0

1.1

6.30

7.03

mg/g

0.62

166

645

Dislocation, sprain and strain of joints and ligaments at neck level

201

1.89

3.42

1.1

1.0

5.97

6.26

mg/g

0.10

194

Transport accidents

477

1.52

3.39

1.1

5.76

6.69

mg/g

0.68

453

Other and unspecified iridocyclitis

3.77

3.39

1.1

1.0

6.93

7.12

mg/g

0.04

Disorders of vitreous body and globe

388

1.61

3.37

1.1

7.28

7.82

mg/g

0.32

367

Human immunodeficiency virus [HIV] disease resulting in other conditions

7.06

3.37

1.0

10.48

6.37

mg/g

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

7.06

3.37

1.0

10.48

6.37

mg/g

—

Immunodeficiencies

3.44

3.31

1.2

1.0

6.90

5.33

mg/g

0.59

Asthma, hospital admissions , main diagnosis only

146

928

1.37

3.30

1.1

7.39

6.95

mg/g

0.24

139

888

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

8.64

3.27

1.0

7.14

5.89

mg/g

—

Other diseases of upper respiratory tract

182

710

1.34

3.24

1.1

6.60

7.16

mg/g

0.46

175

677

Disorders of conjunctiva

157

900

1.35

3.24

1.1

6.13

6.98

mg/g

0.98

151

859

Accidents

140

504

1.39

3.21

1.1

6.42

6.67

mg/g

0.14

133

479

Other facial nerve disorders

5.36

3.19

1.0

4.77

7.33

mg/g

—

Human immunodeficiency virus [HIV] disease

6.41

3.19

1.0

10.48

6.16

mg/g

—

Benign neoplasms

179

731

1.33

3.18

1.1

7.17

6.73

mg/g

0.30

173

702

Bacterial infection, other or unspecified, including avohilmo

444

1.51

3.17

1.1

10.42

6.99

mg/g

1.74

427

Bronchitis

188

856

1.32

3.14

1.1

5.97

7.22

mg/g

1.87

173

826

Diseases of the ear and mastoid process

205

787

1.31

3.11

1.1

6.24

7.13

mg/g

0.96

193

755

Other external causes of accidental injury

139

504

1.38

3.07

1.1

6.48

6.67

mg/g

0.10

132

479

Myeloid leukaemia

7.54

3.06

1.3

1.0

8.40

6.76

mg/g

—

Human immunodeficiency virus [HIV] disease, including avohilmo

5.88

3.02

1.0

10.48

6.11

mg/g

—

Tobacco use

2.90

3.02

1.3

1.0

5.69

8.91

mg/g

1.53

Other specified/unspecified inflammatory spondylopathies

3.35

3.01

1.1

1.0

7.55

6.92

mg/g

0.08

Systemic lupus erythematosus, unspecified

4.31

2.99

1.0

5.81

6.04

mg/g

—

Nonhereditary hypogammaglobulinemia

10.10

2.98

1.6

1.0

6.50

6.66

mg/g

—

Other papulosquamous disorders

10.09

2.98

1.2

1.0

5.58

8.03

mg/g

—

Somnolence

10.08

2.98

1.2

1.0

10.51

6.21

mg/g

—

Panhypopituitarism

10.06

2.98

1.2

1.0

5.18

7.59

mg/g

—

Finngen Rheumatological endpoints

177

762

1.32

2.97

1.1

6.99

6.94

mg/g

0.02

164

734

Other sleep disorders

2.40

2.96

1.2

1.0

6.81

7.82

mg/g

0.29

Event of undetermined intent

2.51

2.87

1.3

1.0

5.36

7.71

mg/g

1.41

Perineal laceration during delivery

270

0.42

2.85

1.0

1.1

5.50

4.84

mg/g

0.48

258

Post-traumatic stress disorder

109

2.12

2.84

1.1

5.59

5.83

mg/g

0.10

109

Dentofacial anomalies [including malocclusion]

140

817

1.34

2.81

1.0

1.1

6.15

6.97

mg/g

0.72

132

781

Disorders of choroid and retina

109

546

1.40

2.78

1.1

8.31

7.40

mg/g

0.66

102

522

Disorders of brain, other and unspecified

8.42

2.75

1.0

10.34

5.22

mg/g

—

Personal history of medical treatment

8.41

2.75

1.0

6.62

5.40

mg/g

—

Scleritis

8.40

2.75

1.0

5.70

6.48

mg/g

—

Shoulder lesions

109

466

1.40

2.75

1.0

1.1

7.93

7.01

mg/g

0.56

102

448

Other abnormalities of plasma proteins

8.39

2.75

1.0

6.48

5.95

mg/g

—

Endocrine, nutritional and metabolic diseases

155

588

1.33

2.75

1.0

1.1

7.27

6.53

mg/g

0.49

147

560

Other acute lower respiratory infections

599

1.43

2.74

1.1

6.86

6.94

mg/g

0.04

573

Psychotic depression

3.01

2.69

1.3

1.1

6.12

8.40

mg/g

0.83

Pneumonias (Asthma/COPD co-morbidities)

177

894

1.29

2.68

1.1

7.77

6.78

mg/g

0.82

167

858

Chronic lower respiratory diseases

210

872

1.27

2.64

1.1

7.06

7.01

mg/g

0.03

199

835

Benign neoplasm: Rectum

2.12

2.64

1.1

7.38

8.99

mg/g

0.54

Anomalies of pupillary function

4.70

2.60

1.1

1.0

6.06

5.51

mg/g

—

Neoplasms

152

604

1.32

2.60

1.1

8.10

6.07

mg/g

0.74

145

582

All pneumoniae

177

896

1.28

2.55

1.1

7.76

6.77

mg/g

0.81

167

860

Major coronary heart disease event

534

0.66

2.55

1.1

7.84

7.66

mg/g

0.06

512

Other and unspecified trigeminal disorders

7.19

2.55

1.4

1.0

6.77

5.88

mg/g

—

Peroneal tendinitis

5.49

2.54

1.0

1.1

5.25

6.57

mg/g

—

Exposure to other and unspecified man-made environmental factors

5.49

2.54

1.0

7.99

6.22

mg/g

—

Osteopathies and chondropathies

554

1.42

2.52

1.1

7.09

mg/g

0.00

533

Disturbances of smell and taste

3.82

2.46

1.1

1.0

4.80

6.08

mg/g

—

Zoster [herpes zoster], including avohilmo

462

1.46

2.43

1.1

10.09

6.96

mg/g

1.27

443

Other bacterial diseases, including avohilmo

170

828

1.28

2.43

1.1

9.44

6.60

mg/g

2.76

159

795

Benign neoplasm: Anus and anal canal

5.02

2.40

1.0

8.79

7.20

mg/g

—

Sequelae of intentional self-harm, assault and events of undetermined intent

6.34

2.38

1.4

1.0

8.63

5.79

mg/g

—

Any event in cancer register

161

730

1.29

2.38

1.1

9.11

6.43

mg/g

1.11

151

701

Drug-induced osteoporosis

6.30

2.37

1.2

1.0

6.50

6.56

mg/g

—

Hypersomnia

6.29

2.37

1.0

7.53

6.30

mg/g

—

Diseases of the respiratory system

105

382

1.38

2.37

1.1

7.06

6.47

mg/g

0.38

368

Constipation

136

703

1.31

2.35

1.1

7.66

6.88

mg/g

0.46

126

673

Other bacterial diseases

145

740

1.30

2.32

1.2

1.1

9.40

7.01

mg/g

1.91

134

715

Inflammatory diseases of female pelvic organs

116

596

1.33

2.26

1.1

5.44

5.94

mg/g

0.70

107

572

Amblyopia ex anopsia

2.87

2.21

1.1

1.0

8.11

6.24

mg/g

—

Other inflammation of eyelid, including avohilmo

633

1.38

2.20

1.1

5.13

6.17

mg/g

2.42

603

Reactive arthropathies, FINNGEN

2.51

2.18

1.0

1.1

10.56

6.95

mg/g

0.44

Other superficial mycoses

4.31

2.15

1.3

1.0

11.63

5.94

mg/g

—

Other and unspecified disease of Bartholin gland

4.30

2.15

1.2

1.0

5.88

5.77

mg/g

—

Myositis

3.70

2.15

1.1

1.0

7.62

6.52

mg/g

—

Arthropathies

168

671

1.27

2.14

1.1

6.82

7.02

mg/g

0.11

162

648

Injuries to the neck

282

1.56

2.13

1.2

1.1

6.22

6.47

mg/g

0.10

274

Rotator cuff syndrome

377

1.41

2.12

1.0

1.1

7.93

7.19

mg/g

0.47

366

Other and unspecified rosacea

2.21

2.10

1.3

1.1

10.81

7.35

mg/g

0.41

Diseases of spleen

5.03

2.07

1.2

1.0

5.84

6.23

mg/g

—

Agoraphobia

2.91

2.07

1.0

5.68

5.20

mg/g

—

Other salmonella infections

3.51

2.05

1.1

1.0

6.35

6.52

mg/g

—

Viral conjunctivitis

4.02

2.04

1.0

4.54

5.89

mg/g

—

Cardiac arrhythmias

113

552

1.31

2.01

1.1

6.19

6.26

mg/g

0.04

108

529

Premature rupture of membranes

297

0.57

1.98

1.0

1.1

4.63

5.30

mg/g

0.68

278

All kidney diseases

163

874

1.25

1.98

1.1

7.92

6.55

mg/g

1.24

149

843

Unspecified event, undetermined intent

3.35

1.96

1.1

1.0

6.35

7.18

mg/g

—

Other keratitis

119

1.85

1.96

1.0

1.1

4.67

7.27

mg/g

2.94

114

Other disorders of pigmentation

3.34

1.96

1.0

5.85

5.57

mg/g

—

Pneumonia, organism unspecified

150

818

1.26

1.94

1.1

8.07

6.73

mg/g

1.03

141

786

Torticollis

4.57

1.94

1.4

1.0

10.92

5.36

mg/g

—

Biological medicines for asthma

3.77

1.93

1.0

10.73

6.02

mg/g

—

Vertical strabismus

2.97

1.93

1.0

6.36

7.04

mg/g

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.97

1.93

1.1

1.0

4.13

6.27

mg/g

—

3.77

1.93

1.0

7.38

6.02

mg/g

—

Autoimmune hepatitis, wide definition

2.97

1.93

1.4

1.0

6.10

6.57

mg/g

—

Chronic iridocyclitis

2.73

1.93

1.1

1.0

4.26

5.94

mg/g

—

Soft tissue disorders related to use, overuse and pressure

218

1.61

1.93

1.1

6.05

7.37

mg/g

1.09

210

Social phobias

113

1.86

1.91

1.0

5.81

6.07

mg/g

0.09

113

COPD/asthma/ILD related infections

164

659

1.25

1.88

1.0

1.1

6.20

7.09

mg/g

0.87

151

636

COPD/asthma related infections

164

659

1.25

1.88

1.0

1.1

6.20

7.09

mg/g

0.87

151

636

Delivery, wide proxy

246

0.60

1.88

1.1

5.70

5.87

mg/g

0.09

237

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

166

894

1.24

1.86

1.1

7.95

6.78

mg/g

0.96

156

859

Disorders of orbit

2.87

1.86

1.4

1.0

9.22

5.88

mg/g

—

Other protozoal intestinal diseases, including avohilmo

3.55

1.84

1.0

4.55

5.39

mg/g

—

Campylobacter enteritis

3.54

1.84

1.0

9.09

6.63

mg/g

—

Intentional self-harm by unspecified means

4.19

1.82

1.4

1.0

6.59

4.88

mg/g

—

Fourth [trochlear] nerve palsy

4.18

1.82

1.0

46.28

6.57

mg/g

—

Drug-induced cataract

4.18

1.82

1.0

5.67

6.38

mg/g

—

Enthesopathies of lower limb, excluding foot

214

1.59

1.81

1.1

1.0

6.49

6.68

mg/g

0.06

205

Other salmonella infections, including avohilmo

2.77

1.79

1.1

1.0

6.48

7.98

mg/g

—

Atopic dermatitis

121

758

1.27

1.79

1.1

5.56

6.68

mg/g

1.35

115

722

Urolithiasis

239

1.55

1.77

1.0

1.1

7.74

7.88

mg/g

0.05

230

Postpartum care and examination

164

0.50

1.75

1.0

1.1

4.34

5.59

mg/g

1.12

154

Burn and corrosion confined to eye and adnexa

3.35

1.75

1.0

6.03

6.25

mg/g

—

Chronic Coagulation defects

3.35

1.75

1.0

6.87

5.92

mg/g

—

Iridocyclitis

217

1.57

1.72

1.0

1.1

5.89

7.14

mg/g

0.97

207

Ischemic heart diseases

557

0.74

1.72

1.1

7.47

7.70

mg/g

0.10

533

Other abnormal findings of blood chemistry

2.67

1.72

1.4

1.0

5.88

7.67

mg/g

—

Sequelae of injuries, of poisoning and of other consequences of external causes

249

1.53

1.72

1.1

6.33

7.05

mg/g

0.59

239

Congenital iodine-deficiency syndrome/hypothyroidism

3.86

1.71

1.6

1.0

4.97

6.55

mg/g

—

Complications of surgical and medical care, not elsewhere classified

155

840

1.23

1.70

1.1

6.60

6.92

mg/g

0.28

149

804

Chronic apical periodontitis

183

846

1.21

1.69

1.1

6.92

7.01

mg/g

0.05

170

812

Monoamine oxidase A inhibitors

2.00

1.69

1.0

1.1

8.31

8.73

mg/g

0.07

LSIL lesion of the cervix uteri, vagina or vulva

196

1.58

1.65

1.0

1.1

5.11

5.35

mg/g

0.17

189

2.80

1.64

1.0

12.64

6.35

mg/g

—

Cardiomyopathy, other and unspecified

2.44

1.64

1.1

10.29

9.08

mg/g

—

Pregnancy, childbirth and the puerperium

207

0.60

1.63

1.0

1.1

5.36

5.73

mg/g

0.25

199

Autoimmune thyroiditis

3.59

1.61

1.4

1.0

4.12

6.03

mg/g

—

Hypertension, essential

125

564

1.25

1.59

1.1

7.98

6.80

mg/g

0.89

114

540

Olecranon bursitis

2.70

1.58

1.3

1.0

6.71

10.43

mg/g

—

Otitis externa, unspecified

121

1.74

1.58

1.0

5.55

7.22

mg/g

1.20

116

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

142

731

1.23

1.54

1.1

6.76

7.33

mg/g

0.46

136

696

Other and unspecified acne

3.35

1.52

2.0

1.0

9.24

7.78

mg/g

—

Alcohol abuse, main dg

161

1.62

1.52

1.2

1.0

8.71

7.21

mg/g

0.42

155

Traumatic subdural haemorrhage

3.34

1.51

1.2

1.0

7.81

6.95

mg/g

—

Gingivitis and periodontal diseases

150

634

1.22

1.51

1.1

6.21

7.10

mg/g

1.04

137

611

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.87

1.50

1.3

1.0

5.12

5.78

mg/g

—

Panniculitis affecting regions of neck and back

2.86

1.50

1.0

7.08

6.35

mg/g

—

Statin medication

123

556

1.25

1.50

1.1

7.25

6.93

mg/g

0.16

116

533

Hordeolum and other deep inflammation of eyelid

2.16

1.50

1.5

1.0

5.20

7.90

mg/g

1.06

Otitis externa

251

1.48

1.47

1.2

1.1

6.46

6.88

mg/g

0.16

241

Malignant neoplasm, including Hilmo

140

667

1.22

1.46

1.1

9.75

6.62

mg/g

1.15

132

635

Acute tubulo-interstitial nephritis

587

1.28

1.46

1.1

6.49

6.64

mg/g

0.10

563

Other disorders of penis

1.84

1.45

1.1

7.00

8.35

mg/g

0.35

Chondromalacia

3.13

1.44

1.0

5.99

6.67

mg/g

—

Other and unspecified mononeuropathies of lower limb

3.13

1.44

1.2

1.0

5.48

6.65

mg/g

—

Manic episode

3.13

1.44

1.0

10.02

6.72

mg/g

—

Primary Sclerosing Cholangitis, IBD and UDCA required

2.74

1.43

1.0

4.71

5.74

mg/g

—

Burns and corrosions confined to eye and internal organs

2.74

1.43

1.0

6.03

6.50

mg/g

—

Anterior Iridocyclitis

188

1.54

1.42

1.0

5.99

7.14

mg/g

0.77

180

Malignant neoplasm, wide definition

140

669

1.22

1.42

1.1

9.73

6.61

mg/g

1.14

132

637

Temporomandibular joint disorders, including avohilmo

670

1.27

1.41

1.0

1.1

6.10

6.00

mg/g

0.05

640

Congenital malformations, deformations and chromosomal abnormalities

108

825

1.24

1.40

1.0

1.1

7.21

6.70

mg/g

0.28

102

787

Malignant neoplasm

134

644

1.22

1.37

1.1

9.91

6.66

mg/g

1.15

126

613

Ingrowing nail

2.20

1.37

1.0

6.52

7.48

mg/g

—

Spasmodic torticollis

2.62

1.37

1.2

1.0

5.60

6.24

mg/g

—

Polycystic kidney disease

2.95

1.36

1.2

1.0

14.20

7.98

mg/g

—

Hodgkin lymphoma, hilmo

2.95

1.36

1.0

12.85

6.36

mg/g

—

Other and unspecified mononeuropathies, also in other diseases

2.95

1.36

1.2

1.1

5.59

7.17

mg/g

—

Chronic conjunctivitis

2.95

1.36

1.4

1.0

5.01

5.59

mg/g

—

Malignant neoplasm

133

640

1.22

1.35

1.1

9.90

6.67

mg/g

1.12

125

609

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

117

871

1.22

1.34

1.0

1.1

7.51

6.79

mg/g

0.42

110

831

Medical abortion

107

466

1.24

1.32

1.0

1.1

5.34

6.02

mg/g

0.76

100

444

Diseases of pulp and periapical tissues, including avohilmo

168

731

1.19

1.31

1.1

7.03

7.08

mg/g

0.03

160

706

Diseases of external ear

376

1.36

1.31

1.1

6.87

7.10

mg/g

0.10

359

Intentional self-harm by sharp object

2.51

1.30

1.0

5.52

5.11

mg/g

—

Injuries to the head

180

907

1.18

1.29

1.1

6.83

7.03

mg/g

0.14

174

865

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

619

1.24

1.29

1.1

5.06

6.37

mg/g

3.70

590

Melanocytic naevi

369

1.36

1.28

1.1

8.03

6.28

mg/g

0.86

355

Cardiodefibrillation

192

0.52

1.28

1.1

12.17

8.83

mg/g

—

180

severe traumatic brain injury, does not include concussion

133

0.45

1.27

1.2

1.1

7.12

8.29

mg/g

—

128

Other epidermal thickening

2.40

1.24

1.0

7.23

6.25

mg/g

—

Other inflammatory liver diseases

2.00

1.23

1.3

1.0

6.34

7.28

mg/g

—

Acute lymphadenitis

1.97

1.22

1.1

1.0

5.14

6.73

mg/g

0.93

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.64

1.21

1.0

1.1

4.73

6.31

mg/g

—

Syphilis

2.64

1.21

1.4

1.0

8.15

6.36

mg/g

—

Syphilis, including avohilmo

2.64

1.21

1.4

1.0

8.15

6.36

mg/g

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.64

1.21

1.0

6.04

6.57

mg/g

—

Use of ropinirole

2.64

1.21

2.4

1.0

5.25

8.91

mg/g

—

Chronic tubulo-interstitial nephritis

2.64

1.21

1.4

1.1

6.93

6.11

mg/g

—

Contact with sharp glass

2.17

1.21

1.1

1.0

4.28

6.72

mg/g

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

141

775

1.19

1.20

1.1

6.25

6.68

mg/g

0.37

135

741

Bipolar affective disorders

205

1.46

1.19

1.2

1.1

5.80

6.98

mg/g

0.63

199

Contusion of toe(s) without damage to nail

2.31

1.19

1.0

9.41

5.79

mg/g

—

Acute alcohol intoxication

247

1.42

1.18

1.2

1.1

7.99

7.79

mg/g

0.06

235

Injuries to the shoulder and upper arm

123

790

1.20

1.18

1.1

6.35

7.51

mg/g

1.46

115

761

Sleep disorders (combined)

169

752

1.17

1.18

1.1

6.61

7.04

mg/g

0.32

163

718

Phlebitis and thrombophlebitis (not including DVT)

181

1.49

1.17

1.1

1.0

8.40

7.82

mg/g

0.10

173

Disorders of synovium and tendon

503

1.26

1.17

1.0

1.1

7.42

6.54

mg/g

0.49

485

Diseases of oesophagus, stomach and duodenum

166

836

1.17

1.16

1.1

7.54

6.79

mg/g

0.50

158

800

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.51

1.15

1.0

1.1

5.38

5.57

mg/g

—

Idiopathic urticaria

2.51

1.15

1.4

1.0

6.15

5.72

mg/g

—

Exclusions for E4_PCOS_CONSORTIUM

127

662

1.20

1.15

1.1

6.21

5.88

mg/g

0.27

116

637

DVT of lower extremities

110

1.64

1.15

1.1

6.51

8.00

mg/g

0.62

104

Atrophic disorders of skin

142

1.55

1.14

1.2

1.1

5.71

6.86

mg/g

0.79

135

Other acquired deformities of musculoskeletal system and connective tissue

2.34

1.12

1.3

1.0

7.71

8.54

mg/g

—

Dermatophytosis, including avohilmo

101

816

1.21

1.12

1.1

7.55

7.13

mg/g

0.20

782

Other skin changes

119

1.60

1.11

1.1

7.43

8.27

mg/g

0.17

114

Maternal care for known or suspected fetal abnormality and damage

269

1.36

1.11

1.2

1.1

5.41

5.11

mg/g

0.13

249

Erosion of teeth , including avohilmo

389

1.31

1.09

1.1

6.71

6.54

mg/g

0.06

375

170

740

1.16

1.09

1.0

1.1

6.22

7.30

mg/g

1.18

157

714

Blood alcohol or alcohol intoxication level

2.39

1.09

1.6

1.0

6.30

7.65

mg/g

—

Alcohol-induced acute pancreatitis

2.39

1.09

1.0

11.41

8.83

mg/g

—

Excessive earwax

600

0.77

1.08

1.0

1.1

7.95

7.31

mg/g

0.25

573

Injury of nerves at wrist and hand level

2.19

1.08

1.0

4.35

7.76

mg/g

—

Bulimia nervosa (incl. atypical)

1.93

1.06

1.0

6.97

5.10

mg/g

—

Hypothyroidism, other/unspecified

136

760

1.18

1.04

1.1

6.10

6.69

mg/g

0.60

130

727

Generalized epilepsy, strict definition

2.28

1.03

1.0

5.15

6.30

mg/g

—

Contact with sharp object, undetermined intent

2.28

1.03

1.8

1.0

4.65

7.31

mg/g

—

Cystic kidney disease

2.28

1.03

1.2

1.0

14.20

6.85

mg/g

—

Carcinoma in situ of other and unspecified digestive organs

2.28

1.03

1.4

1.0

6.64

8.59

mg/g

—

Meniscus derangement

388

1.25

1.02

1.0

1.1

7.21

7.50

mg/g

0.15

374

Acute and subacute iridocyclitis

179

1.45

1.02

1.0

1.1

6.22

7.32

mg/g

0.65

170

Other and unspecified anaemias

272

1.35

1.00

1.2

1.0

8.28

7.83

mg/g

0.09

259

Hypertensive diseases (excluding secondary)

435

1.22

1.00

1.0

1.1

7.47

6.37

mg/g

0.61

412

Deviated nasal septum

308

1.33

0.98

1.1

9.57

8.05

mg/g

0.51

292

Hypercalcemia

2.18

0.98

1.4

1.0

9.77

6.26

mg/g

—

Gluteal tendinitis

2.18

0.98

1.2

1.0

6.67

6.62

mg/g

—

Open wound of hip and thigh

0.00

0.97

0.0

1.0

—

8.16

—

Mental and behavioural disorders due to alcohol

513

1.24

0.97

1.1

7.12

7.53

mg/g

0.23

492

Diseases of the skin and subcutaneous tissue

156

676

1.16

0.96

1.1

6.83

7.00

mg/g

0.10

148

646

Gastro-oesophageal reflux disease

677

1.20

0.94

1.1

6.18

7.09

mg/g

0.85

645

Special screening examination for neoplasms

1.89

0.94

1.0

1.1

6.08

8.98

mg/g

—

Contact with and exposure to communicable diseases

520

0.77

0.93

1.1

5.27

5.83

mg/g

0.46

498

Urticaria and erythema

489

1.25

0.92

1.1

5.88

6.24

mg/g

0.26

468

Nail disorders

1.72

0.92

1.0

1.1

6.38

7.36

mg/g

0.35

Benign neoplasm: Long bones of lower limb

2.15

0.91

1.0

10.79

7.72

mg/g

—

Other anaemias

276

1.32

0.91

1.2

1.0

8.28

7.79

mg/g

0.10

263

Ovarian cyst

273

1.26

0.90

1.1

5.33

5.70

mg/g

0.19

262

Other CVD

1.60

0.90

1.2

1.1

6.46

8.60

mg/g

0.94

Corneal ulcer

207

0.63

0.90

1.2

1.1

7.80

7.03

mg/g

0.17

197

Asthma/COPD (KELA code 203)

150

872

1.15

0.89

1.1

7.25

7.01

mg/g

0.12

142

835

Injury of muscle and tendon at lower leg level

127

1.50

0.88

1.1

8.61

7.60

mg/g

0.27

121

Hyperparathyroidism

1.58

0.87

1.1

7.33

7.71

mg/g

0.08

Benign thyroid growths and nodules

267

0.70

0.85

1.0

1.1

8.34

7.06

mg/g

0.28

252

Other surgical follow-up care

1.94

0.84

1.0

5.30

6.78

mg/g

—

Actinic keratosis

185

0.64

0.84

1.2

1.1

12.46

8.92

mg/g

0.38

174

Convergent concomitant strabismus

1.76

0.83

1.1

1.0

4.01

7.34

mg/g

—

Acute alcohol intoxication, ICD10

222

1.35

0.83

1.2

1.1

8.43

6.84

mg/g

0.55

215

Diabetes, insulin treatment (Kela reimbursement)

115

793

0.86

0.82

1.0

1.1

8.72

7.17

mg/g

1.26

110

757

Other obstructive and reflux uropathy

1.82

0.79

1.0

5.00

7.67

mg/g

—

Prepatellar bursitis

0.00

0.79

0.0

1.0

—

10.40

—

Complications associated with artificial fertilization

0.00

0.78

0.0

1.0

—

5.24

—

Seronegative juvenile rheumatoid arthritis

0.00

0.77

0.0

1.0

—

4.36

—

561

1.19

0.77

1.1

7.43

7.74

mg/g

0.14

536

Tongue abnormality

1.77

0.76

1.2

1.0

7.42

6.02

mg/g

—

Endometriosis of intestine

2.09

0.74

1.0

4.86

5.05

mg/g

—

Abscess of Bartholin gland

2.09

0.74

1.0

4.40

5.55

mg/g

—

Haemolytic anaemias

2.09

0.74

1.0

3.93

5.37

mg/g

—

Postprocedural disorders of digestive system, not elsewhere classified

2.09

0.74

1.2

1.0

11.33

7.47

mg/g

—

Skin changes due to chronic exposure to nonionizing radiation

189

0.67

0.74

1.1

11.81

8.87

mg/g

0.33

178

Conductive and sensorineural hearing loss

532

0.84

0.74

1.0

1.1

7.53

7.71

mg/g

0.07

512

Congenital malformations of uterus and cervix

2.01

0.72

1.2

1.0

5.44

5.37

mg/g

—

Cystic kidney disease, including avohilmo

2.00

0.72

1.2

1.0

14.20

6.75

mg/g

—

Other specified and unspecified retinal disorders

2.00

0.72

1.0

9.35

6.10

mg/g

—

Herpesviral keratitis and keratoconjunctivitis

2.00

0.72

1.0

10.25

6.66

mg/g

—

Renal tubulo-interstitial diseases

124

796

1.14

0.72

1.1

8.06

6.54

mg/g

1.13

116

762

Chronic kidney disease

169

1.37

0.72

1.0

1.1

10.05

8.03

mg/g

0.55

162

Autoimmune hyperthyroidism

1.80

0.72

1.3

1.1

6.53

6.42

mg/g

—

Nonischemic cardiomyopathy

1.61

0.72

1.0

1.1

5.23

8.68

mg/g

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.67

0.72

1.1

1.0

4.61

6.69

mg/g

—

Fracture of skull and facial bones

246

1.30

0.71

1.2

1.1

6.26

7.45

mg/g

0.82

237

Other or ill-defined heart diseases

1.75

0.71

1.1

1.0

7.15

8.93

mg/g

—

Caught, crushed, jammed or pinched in or between objects

1.58

0.71

1.0

6.21

7.52

mg/g

—

Solid cancers, including Hilmo

126

644

1.14

0.71

1.1

9.39

6.67

mg/g

0.86

119

613

Symptoms and signs involving emotional state

1.93

0.70

1.0

5.37

5.04

mg/g

—

206

0.70

1.1

10.83

8.75

mg/g

0.25

193

Alcohol use disorder, ICD-based

428

1.22

0.67

1.1

7.54

7.55

mg/g

0.01

409

Primary open-angle glaucoma

147

1.37

0.66

1.1

10.22

8.58

mg/g

0.42

138

Nontoxic goitre/thyroid nodule

249

0.72

0.66

1.0

1.1

8.49

7.29

mg/g

0.23

235

Impacted maxillary molar

0.53

0.66

1.0

4.61

5.17

mg/g

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.53

0.66

1.2

1.1

12.30

8.48

mg/g

—

Haemorrhage in early pregnancy

393

0.79

0.64

1.2

1.1

4.19

5.64

mg/g

4.36

369

Benign neoplasm: Colon, unspecified

146

1.37

0.63

1.1

9.16

8.92

mg/g

0.03

137

Solid cancers

119

616

1.13

0.63

1.1

9.61

6.72

mg/g

0.87

112

586

Hypertensive diseases

121

604

1.13

0.62

1.1

7.99

6.71

mg/g

0.97

111

578

Hypertension

121

604

1.13

0.62

1.1

7.99

6.71

mg/g

0.97

111

578

Mental and behavioural disorders due to alcohol, excluding acute intoxication

457

1.19

0.61

1.1

7.31

7.68

mg/g

0.16

437

Kidney transplant status

1.57

0.60

1.1

1.0

8.90

8.85

mg/g

—

Other symptoms and signs involving the digestive system and abdomen

140

0.64

0.60

1.0

13.01

7.03

mg/g

—

135

Ovarian hyperstimulation (induction)

0.00

0.60

0.0

1.0

—

5.26

—

Other heart diseases, wide

152

828

1.11

0.59

1.0

1.1

6.22

7.05

mg/g

0.83

146

795

Alcohol use disorder, Swedish definition

512

1.17

0.59

1.1

7.56

7.45

mg/g

0.05

489

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

113

754

0.89

0.58

1.0

1.1

8.68

7.13

mg/g

1.23

108

718

0.00

0.58

0.0

1.0

—

5.13

—

Inflammatory diseases of prostate (prostatitis)

1.48

0.57

1.0

8.77

9.13

mg/g

0.04

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

120

1.37

0.55

1.0

1.1

8.46

8.27

mg/g

0.05

111

Viral conjunctivitis, including avohilmo

1.62

0.55

1.0

4.54

7.86

mg/g

—

Polyarthropathies

550

1.13

0.55

1.1

7.52

6.97

mg/g

0.32

532

Injury of eye and orbit

168

1.31

0.54

1.0

1.1

7.38

7.26

mg/g

0.03

163

Heart failure and coronary heart disease

184

0.76

0.54

1.2

1.1

9.42

8.60

mg/g

0.20

178

Caries of dentine, including avohilmo

489

0.88

0.53

1.1

6.81

6.87

mg/g

0.03

471

Generalized epilepsy

1.54

0.53

1.2

1.0

6.21

6.56

mg/g

—

Diseases of appendix

110

883

1.11

0.50

1.1

6.63

7.09

mg/g

0.27

105

845

Hypertrophy of breast

191

0.73

0.50

1.0

5.04

5.89

mg/g

0.65

181

Appendicitis, broad definition

109

878

1.11

0.50

1.1

6.61

7.08

mg/g

0.27

104

840

Foreign body in alimentary tract

1.56

0.49

1.0

3.90

8.30

mg/g

—

Fitting and adjustment of other devices

206

0.77

0.47

1.2

1.1

7.16

8.45

mg/g

0.62

194

Schizophrenia

177

0.73

0.47

1.0

1.1

5.65

7.01

mg/g

0.82

171

Glucosamine medication

220

0.80

0.44

1.1

6.88

8.99

mg/g

1.39

207

589

1.12

0.42

1.1

7.43

7.60

mg/g

0.08

563

Gingival hyperplasia

1.56

0.42

1.0

3.32

6.64

mg/g

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

1.56

0.42

1.0

4.54

8.18

mg/g

—

Dysplasia of cervi uteri

245

1.18

0.42

1.0

1.1

4.91

5.57

mg/g

0.61

234

malignant neoplasm of female genital organs

0.63

0.42

1.0

1.1

10.58

7.17

mg/g

—

Nontoxic multinodular goitre

139

0.72

0.41

1.0

1.1

8.34

7.14

mg/g

—

131

Non-ischemic cardiomyopathy

164

0.77

0.41

1.0

1.1

5.51

8.40

mg/g

3.09

157

Congenital malformations of cardiac chambers and connections

0.00

0.41

0.0

1.0

—

6.44

—

Other congenital malformations of male genital organs

0.00

0.41

0.0

1.1

—

6.82

—

Glucagon-like peptide-1 (GLP-1) analogues

305

0.82

0.41

1.0

1.1

9.67

7.59

mg/g

0.50

285

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

305

0.82

0.41

1.0

1.1

9.67

7.59

mg/g

0.50

285

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.41

0.0

1.0

—

8.49

—

Anxious personality disorder

0.00

0.41

0.0

1.0

—

5.49

—

Benign neoplasm: Tongue

0.00

0.41

0.0

1.0

—

6.43

—

Problems related to social environment

0.00

0.41

0.0

1.0

—

8.60

—

Other congenital malformations of male genital organs, including avohilmo

0.00

0.41

0.0

1.1

—

6.76

—

Dependent personality disorder

0.00

0.41

0.0

1.0

—

6.49

—

Oral leukoplakia, including avohilmo

0.00

0.41

0.0

1.0

—

6.33

—

Infective bursitis

0.00

0.40

0.0

1.0

—

10.89

—

Benign neoplasm of thyroid gland

0.00

0.40

0.0

1.1

—

6.48

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

1.47

0.40

1.4

1.0

4.06

5.80

mg/g

—

Schizotypal disorder

0.00

0.40

0.0

1.0

—

6.33

—

Short Achilles tendon (acquired)

0.00

0.40

0.0

1.1

—

5.99

—

Seborrhoeic keratosis

160

0.75

0.39

1.2

1.1

11.07

8.13

mg/g

0.27

149

Atrial septal defect, secundum type

1.43

0.39

1.0

1.1

4.57

5.64

mg/g

—

Whooping cough, including avohilmo

0.00

0.39

0.0

1.0

—

5.55

—

Periodontal disease, other/unspecified

0.00

0.39

0.0

1.0

—

6.09

—

Hypertrophy of breast in women and men

214

0.79

0.37

1.0

5.89

6.39

mg/g

0.24

204

Labour and delivery complicated by fetal stress [distress]

322

0.87

0.37

1.1

5.00

5.31

mg/g

0.19

304

Other abnormal products of conception

355

1.13

0.37

1.1

5.43

5.40

mg/g

0.01

338

Other and unspecified injuries of wrist and hand

1.35

0.37

1.0

4.96

5.70

mg/g

—

malignant neoplasm of female genital organs, including Hilmo

109

0.70

0.37

1.3

1.1

11.71

7.00

mg/g

—

102

Sleep apnoea

127

738

1.08

0.37

1.1

7.43

7.37

mg/g

0.03

121

704

Aplastic and other anaemias

316

1.16

0.36

1.2

1.1

8.19

7.92

mg/g

0.05

301

Dental operations

358

0.89

0.36

1.1

7.23

7.40

mg/g

0.06

345

Malignant neoplasm of digestive organs

171

0.80

0.35

1.2

1.1

10.56

8.15

mg/g

0.36

161

Crohn disease (strict definition, all UC cases excluded)

1.40

0.35

1.0

4.36

6.83

mg/g

—

Endometriosis

267

1.13

0.34

1.1

7.70

5.75

mg/g

0.90

256

Hypothyroidism, strict autoimmune, 3 medication purchases required

116

720

1.08

0.34

1.1

6.13

6.39

mg/g

0.20

110

687

Nontoxic single thyroid nodule

1.33

0.33

1.0

1.1

9.51

7.34

mg/g

—

Sensorineural hearing loss

467

0.90

0.33

1.0

1.1

7.85

8.00

mg/g

0.06

448

Dipeptidyl peptidase 4 (DPP-4) inhibitors

317

0.87

0.33

1.1

9.83

8.08

mg/g

0.43

298

Artrosis, including avohilmo

103

612

0.92

0.33

1.1

6.15

7.49

mg/g

1.46

588

Congenital deformities of feet, including avohilmo

1.28

0.32

1.0

22.62

6.12

mg/g

—

Dermatitis due to substances taken internally

1.28

0.32

1.0

5.55

6.57

mg/g

—

Disorders of breast

576

1.10

0.31

1.1

5.18

6.08

mg/g

1.11

552

Disorders of the thyroid gland

132

800

1.07

0.30

1.1

5.97

6.70

mg/g

0.90

126

763

Diabetes mellitus

140

861

0.94

0.29

1.1

8.03

6.76

mg/g

1.19

135

823

Hernia

127

789

1.07

0.29

1.1

8.24

7.27

mg/g

0.50

118

755

Leiomyoma of uterus

433

1.09

0.28

1.1

8.12

6.02

mg/g

1.27

412

Gastroduodenal ulcer

139

1.22

0.28

1.1

10.02

8.73

mg/g

0.28

134

Gonarthrosis [arthrosis of knee](FG)

434

0.91

0.28

1.1

6.71

7.77

mg/g

0.76

416

Cellulitis

233

1.16

0.27

1.2

1.0

11.43

6.87

mg/g

0.80

223

Abnormalities of forces of labour

139

0.79

0.26

1.0

1.1

4.86

5.36

mg/g

0.37

130

Heart failure,strict

254

0.88

0.26

1.1

8.20

9.00

mg/g

0.28

238

Kela-code for severe mental illness

457

0.90

0.25

1.1

5.35

7.11

mg/g

1.98

435

Female infertility, associated with anovulation

149

0.80

0.25

1.1

4.17

4.88

mg/g

0.79

144

Acute pharyngitis

223

1.15

0.25

1.1

1.0

4.98

6.26

mg/g

1.23

218

Acute appendicitis

860

1.07

0.24

1.1

6.66

7.08

mg/g

0.21

822

Malignant neoplasm of digestive organs, including Hilmo

187

0.86

0.23

1.1

9.72

8.22

mg/g

0.25

177

Other disorders of breast

143

1.19

0.23

1.0

4.24

5.62

mg/g

1.64

138

Heart failure and bmi 25plus

127

0.84

0.23

1.1

10.63

9.16

mg/g

0.31

119

Other diseases of anus and rectum

242

0.86

0.23

1.0

7.95

7.44

mg/g

0.12

231

All-cause Heart Failure

250

0.89

0.23

1.1

8.07

8.90

mg/g

0.30

236

Ankylosing spondylitis, strict definition

1.28

0.23

1.0

5.10

8.87

mg/g

—

Fracture of shoulder and upper arm

370

1.11

0.22

1.0

1.1

6.00

7.01

mg/g

0.96

355

Diabetes, varying definitions

141

859

0.95

0.21

1.1

8.03

6.76

mg/g

1.18

136

821

Other congenital malformations of limb(s)

0.00

0.21

0.0

1.0

—

5.24

—

Unequal limb length (acquired)

0.00

0.21

0.0

1.0

—

5.82

—

Prominent ears

0.00

0.21

0.0

1.0

—

5.00

—

Diseases caused by chlamydiae

0.00

0.21

0.0

1.0

—

5.80

—

Measles

0.00

0.21

0.0

1.0

—

5.78

—

Migraine without aura, drug-induced

0.00

0.21

0.0

1.0

—

6.51

—

Measles, including avohilmo

0.00

0.21

0.0

1.0

—

5.78

—

Donors of organs and tissues

0.00

0.21

0.0

1.0

—

5.65

—

Open wound of thorax

0.00

0.21

0.0

1.0

—

6.07

—

Adhesive middle ear disease

0.00

0.21

0.0

1.0

—

5.61

—

Other infestations, including avohilmo

0.00

0.21

0.0

1.0

—

5.88

—

Paranoid personality disorder

0.00

0.21

0.0

1.0

—

6.49

—

Pyogenic granuloma

0.00

0.21

0.0

1.0

—

5.83

—

Other bursitis of hip

0.00

0.21

0.0

1.0

—

7.09

—

Amputation of ankle bones

0.00

0.21

0.0

1.0

—

7.04

—

Ectopic testis

0.00

0.21

0.0

1.1

—

7.13

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

1.0

—

6.07

—

Deep bite that required surgery

0.00

0.21

0.0

1.0

—

6.10

—

HSIL lesion of the vulva

0.00

0.21

0.0

1.0

—

5.96

—

Tularaemia, including avohilmo

0.00

0.21

0.0

1.0

—

6.72

—

Benign neoplasm: Duodenum

0.00

0.21

0.0

1.0

—

6.95

—

Other conjunctival vascular disorders and cysts

0.00

0.21

0.0

1.0

—

6.67

—

Other disorders of ear

109

744

0.95

0.21

1.1

7.13

7.19

mg/g

0.03

101

716

Other abnormal uterine and vaginal bleeding

188

0.88

0.20

1.0

1.1

5.62

5.78

mg/g

0.09

180

Complex cardiac defects

0.00

0.20

0.0

1.0

—

7.52

—

Coarctation of the aorta

0.00

0.20

0.0

1.0

—

5.87

—

Diseases caused by chlamydiae, including avohilmo

0.00

0.20

0.0

1.0

—

5.93

—

Cutaneous abscess, furuncle and carbuncle

324

0.89

0.20

1.0

1.1

7.20

6.66

mg/g

0.27

312

Other diseases caused by chlamydiae, including avohilmo

0.00

0.20

0.0

1.0

—

5.93

—

conjunctival degenerations and deposits

0.00

0.20

0.0

1.0

—

6.43

—

Toxic effect of alcohol

0.00

0.20

0.0

1.0

—

6.53

—

Intussusception

0.00

0.20

0.0

1.1

—

6.08

—

HSIL lesion of the cervix uteri

292

0.89

0.20

1.0

1.1

5.05

5.29

mg/g

0.15

278

Heart failure, strict

261

0.90

0.19

1.1

7.97

9.13

mg/g

0.47

245

Disorders of continuity of bone

1.22

0.19

1.2

1.1

5.62

7.22

mg/g

0.66

Struck by thrown, projected or falling objec

1.15

0.19

1.2

1.0

5.07

8.13

mg/g

—

Alcohol dependence

241

1.12

0.19

1.1

6.95

8.43

mg/g

0.74

228

Foreign body on external eye

154

0.84

0.19

1.0

8.06

7.95

mg/g

0.02

149

All dysplastic lesions of the cervix uteri

427

1.08

0.18

1.0

1.1

4.95

5.31

mg/g

0.38

403

Long labour

352

0.91

0.18

1.1

6.63

5.37

mg/g

0.42

332

Ectopic pregnancy

216

0.88

0.17

1.2

1.1

5.92

5.97

mg/g

0.02

206

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

101

1.19

0.16

1.0

5.20

8.03

mg/g

2.05

Benign neoplasm: Sigmoid colon

102

1.18

0.15

1.0

1.1

12.68

8.51

mg/g

0.67

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.81

0.14

1.0

4.58

8.59

mg/g

—

Colorectal cancer, including Hilmo

122

1.15

0.14

1.1

6.73

8.46

mg/g

1.08

115

Gonarthrosis,primary

493

0.95

0.13

1.1

7.11

8.00

mg/g

0.66

470

Primary open-angle glaucoma, strict

122

1.14

0.13

1.1

10.01

8.37

mg/g

0.35

115

Redundant prepuce, phimosis and paraphimosis

215

1.10

0.13

1.1

8.90

9.67

mg/g

0.19

205

Diabetes medication

144

868

0.97

0.12

1.1

8.06

6.78

mg/g

1.20

139

830

Infections of the skin and subcutaneous tissue

784

1.04

0.11

1.1

8.13

6.96

mg/g

0.51

746

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

142

870

1.03

0.11

1.1

6.52

6.75

mg/g

0.18

136

832

Disorders of gallbladder, biliary tract and pancreas

124

747

1.03

0.11

1.1

7.29

7.03

mg/g

0.15

116

714

Pregnancy examination and test

174

0.93

0.10

1.1

7.75

5.70

mg/g

0.47

163

Fentanyl

1.13

0.10

1.0

12.44

10.05

mg/g

—

Unspecified urinary incontinence

1.09

0.09

1.4

1.0

17.00

6.90

mg/g

—

Missing teeth due to accident, extraction or parodontitis

514

1.04

0.09

1.1

7.83

7.69

mg/g

0.05

492

Heart failure and antihypertensive medication

113

1.09

0.09

1.1

6.34

8.41

mg/g

1.17

105

Cholelithiasis

661

0.97

0.08

1.1

7.26

7.08

mg/g

0.09

630

Crohn disease (strict definition, require KELA, min 2 HDR)

1.09

0.08

1.0

4.36

7.30

mg/g

—

Crohn disease (strict definition, require KELA)

1.09

0.08

1.0

4.36

7.30

mg/g

—

Poor fetal growth

205

0.93

0.08

1.2

1.1

6.46

4.73

mg/g

0.37

200

Benign mammary dysplasia

1.12

0.07

1.2

1.1

5.80

6.48

mg/g

0.30

Dental caries, including avohilmo

422

0.97

0.07

1.1

7.07

7.21

mg/g

0.06

409

Polycystic ovarian syndrome

0.88

0.06

1.3

1.0

5.26

4.58

mg/g

—

Cholelithiasis, broad definition with cholecystitis

674

0.98

0.06

1.1

7.15

7.06

mg/g

0.05

642

Hernia of abdominal wall

444

1.04

0.06

1.1

9.15

7.28

mg/g

0.43

426

Other diseases of hard tissues of teeth

291

1.03

0.05

1.1

7.59

7.34

mg/g

0.08

283

Arthrosis

464

0.98

0.04

1.1

7.39

7.28

mg/g

0.05

447

Other complications of labour and delivery, not elsewhere classified

212

1.04

0.04

1.1

6.00

4.86

mg/g

0.33

205

Diseases of arteries, arterioles and capillaries

398

0.98

0.03

1.1

7.77

8.18

mg/g

0.16

380

Combinations of oral blood glucose lowering drugs

189

0.95

0.03

1.0

1.1

8.47

8.49

mg/g

0.01

176

Periodontitis

125

805

0.99

0.02

1.1

7.63

7.05

mg/g

0.35

116

773

Conduction disorders

169

1.04

0.02

1.0

1.1

6.05

8.02

mg/g

1.63

163

Chronic periodontitis, including avohilmo

125

804

0.99

0.02

1.1

7.64

7.06

mg/g

0.35

116

772

Colorectal cancer

112

0.94

0.01

1.1

7.21

8.63

mg/g

0.63

105

Gestational [pregnancy-induced] hypertension

412

1.02

0.01

1.0

1.1

4.95

5.41

mg/g

0.57

390

Seropositive rheumatoid arthritis, strict definition

106

0.94

0.01

1.0

5.16

8.07

mg/g

—

Diseases of pulp and periapical tissues and dental caries

381

1.01

0.00

1.1

7.43

7.34

mg/g

0.03

370

Type 2 diabetes, definitions combined, including avohilmo

128

736

1.00

0.00

1.0

1.1

7.83

6.77

mg/g

1.05

123

702

Other (seronegative) rheumatoid arthritis, wide

127

1.02

0.00

1.1

5.73

7.56

mg/g

1.48

119

Spondylolisthesis/Spondylolysis

126

1.03

0.00

1.1

1.0

6.03

6.97

mg/g

0.56

120

Other noninflammatory disorders of uterus, except cervix

122

0.98

0.00

1.0

1.1

9.02

6.48

mg/g

0.49

117

Maternal care for known or suspected abnormality of pelvic organs

310

1.00

0.00

1.0

1.1

6.47

5.55

mg/g

0.32

289

Pacemaker

168

1.00

0.00

1.0

1.1

7.09

8.87

mg/g

0.91

161

Psoriasis vulgaris

165

0.97

0.00

1.1

8.75

7.19

mg/g

0.32

156

Carbimazole or st.post thyroidectomy, condition for graves disease

215

1.02

0.00

1.2

1.1

7.47

6.67

mg/g

0.20

205

Polyarthrosis

123

1.02

0.00

1.0

1.1

7.74

8.13

mg/g

0.08

118

Carpal tunnel syndrome

551

1.01

0.00

1.0

1.1

7.47

7.08

mg/g

0.18

529

Heart failure, not strict

469

1.00

0.00

1.2

1.1

8.57

7.81

mg/g

0.36

444

Ovarian dysfunction

111

0.99

0.00

1.2

1.1

5.20

4.92

mg/g

0.16

111

Antepartum haemorrhage, not elsewhere classified

146

1.03

0.00

1.0

1.1

4.48

4.95

mg/g

0.49

138

Supervision of normal pregnancy

208

0.99

0.00

1.1

4.60

5.83

mg/g

1.49

194

Hallux valgus (acquired)

217

0.99

0.00

1.0

1.1

5.70

6.75

mg/g

1.02

208

Sleep apnoea, including avohilmo

128

776

1.00

0.00

1.1

7.19

7.29

mg/g

0.05

122

741

Other mosquito-borne viral fevers, including avohilmo

0.00

0.0

1.0

—

5.66

—

Benign neoplasm of other and unspecified intrathoracic organs

0.00

0.0

1.0

—

6.56

—

Combined immunodeficiencies

0.00

0.0

1.0

—

5.54

—

Ankylosing hyperostosis [Forestier]

0.00

0.0

1.0

—

7.14

—

Burns and corrosions of multiple body regions

0.00

0.0

1.0

—

6.94

—

Complications specific to multiple gestation

0.00

0.0

1.0

—

4.82

—

Hypertrophy of (infrapatellar) fat pad

0.00

0.0

1.0

—

7.58

—

Intentional self-harm by jumping from a high place

0.00

0.0

1.0

—

4.95

—

Lung transplant status

0.00

0.0

1.0

—

6.37

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.0

—

8.97

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.0

—

3.04

—

Congenital aortic valve stenosis

0.00

0.0

1.0

—

11.95

—

Cleft lip

0.00

0.0

1.0

—

6.03

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

7.32

—

Morphin

0.00

0.0

1.0

—

8.70

—

Embolic stroke with flimmer

0.00

0.0

1.0

—

7.69

—

Ankylosis of joint

0.00

0.0

1.0

—

7.36

—

Other and unspecified nonscarring hair loss

0.00

0.0

1.0

—

4.74

—

Tularaemia

0.00

0.0

1.0

—

8.23

—

Postdysenteric arthropathy

0.00

0.0

1.0

—

6.40

—

Hypertrophy of tongue papillae

0.00

0.0

1.0

—

6.19

—

Gastrojejunal ulcer

0.00

0.0

1.0

—

6.46

—

Hyphaema and other vascular disorders of iris and ciliary body

0.00

0.0

1.0

—

6.59

—

Hypotension due to drugs

0.00

0.0

1.0

—

7.67

—

Other bursitis, not elsewhere classified

0.00

0.0

1.0

—

6.89

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.0

1.0

—

5.73

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.1

—

7.20

—

Abscess of external ear

0.00

0.0

1.0

—

6.45

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.0

—

2.56

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

0.00

-0.00

0.0

1.0

—

5.96

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.1

—

4.56

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.2

—

2.56

—

Cleft lip and palate

0.00

-0.00

0.0

1.0

—

5.82

—

Lung transplantation

0.00

-0.00

0.0

1.0

—

6.37

—

Other acquired deformities of ankle and foot

0.00

-0.00

0.0

1.0

—

6.31

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.0

—

4.79

—

Bicornuate uterus

0.00

-0.00

0.0

1.0

—

5.55

—

Other crystal arthropathies

0.00

-0.00

0.0

1.0

—

6.06

—

Congenital cataract

0.00

-0.00

0.0

1.0

—

4.97

—

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

-0.00

0.0

1.0

—

8.75

—

Endometriosis in cutaneous scar

0.00

-0.00

0.0

1.0

—

6.26

—

Benign neoplasm: Nasopharynx

0.00

-0.00

0.0

1.0

—

6.02

—

Benign neoplasm: Oesophagus

0.00

-0.00

0.0

1.0

—

7.33

—

Cardiomyopathy, Hypertrophic obstructive

0.00

-0.00

0.0

1.0

—

6.79

—

Moderate visual impairment, binocular

0.00

-0.00

0.0

1.0

—

5.24

—

Benign neoplasm: Vagina

0.00

-0.00

0.0

1.0

—

5.28

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

-0.00

0.0

1.0

—

6.90

—

Carcinoma in situ of skin of lower limb, including hip

0.00

-0.00

0.0

1.0

—

5.76

—

Androgenic alopecia

0.00

-0.00

0.0

1.0

—

6.43

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.0

—

4.72

—

Malignant neoplasm of other and unspecified female genital organs

0.00

-0.00

0.0

1.1

—

5.07

—

Retinoschisis and retinal cysts

0.00

-0.00

0.0

1.0

—

6.33

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

1.0

—

4.27

—

Scarlet fever, including avohilmo

0.00

-0.00

0.0

1.0

—

4.44

—

Whooping cough

0.00

-0.00

0.0

1.0

—

4.70

—

Other nonscarring hair loss

0.00

-0.00

0.0

1.0

—

6.12

—

Universal erythroderma, KELA reimbursement

0.00

-0.00

0.0

1.0

—

6.28

—

Exfoliative dermatitis

0.00

-0.00

0.0

1.0

—

6.92

—

Flatulence and related conditions

0.00

-0.00

0.0

1.0

—

7.36

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

-0.00

0.0

1.0

—

5.84

—

Injury of cranial nerves

0.00

-0.00

0.0

1.0

—

6.60

—

Crystal arthropathies, rheuma endpoint

0.00

-0.00

0.0

1.0

—

6.69

—

Maxillary prognathism

0.00

-0.00

0.0

1.0

—

3.51

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

0.00

-0.00

0.0

1.0

—

7.27

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.0

—

5.44

—

Hypothermia

0.00

-0.00

0.0

1.0

—

7.21

—

Benign neoplasm: Bronchus and lung

0.00

-0.00

0.0

1.0

—

7.33

—

Portal vein thrombosis

0.00

-0.00

0.0

1.0

—

7.22

—

Diffuse brain injury

0.00

-0.00

0.0

1.0

—

7.39

—

Cleft lip and cleft lip and palate

0.00

-0.00

0.0

1.0

—

5.14

—

Congenital malformations of gallbladder, bile ducts and liver

0.00

-0.00

0.0

1.0

—

9.70

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.0

—

10.11

—

Other congenital malformations of skull and face bones

0.00

-0.00

0.0

1.0

—

5.32

—

Traumatic ischaemia of muscle

0.00

-0.00

0.0

1.0

—

6.97

—

Injury of blood vessels at wrist and hand level

0.00

-0.00

0.0

1.0

—

7.87

—

Open wound of neck

0.00

-0.00

0.0

1.0

—

6.48

—

Hypertension, Pulmonary Arterial

0.00

-0.00

0.0

1.0

—

4.75

—

Other and unspecified injuries of neck

0.00

-0.00

0.0

1.0

—

6.26

—

Poisoning by medicine, drug-induced

0.00

-0.00

0.0

1.0

—

6.52

—

Other injuries of upper limb, level unspecified

0.00

-0.00

0.0

1.0

—

5.96

—

Toxic effect of other gases, fumes and vapours

0.00

-0.00

0.0

1.0

—

5.92

—

Assault by other specified means

0.00

-0.00

0.0

1.0

—

6.16

—

Congenital malformations of posterior segment of eye

0.00

-0.00

0.0

1.0

—

13.03

—

Foreign body or object entering through skin

0.95

-0.00

1.0

7.57

8.66

mg/g

—

Congenital malformations of spine and bony thorax, including avohilmo

0.00

-0.00

0.0

1.0

—

5.04

—

Exposure to unspecified smoke, fire and flames

0.00

-0.00

0.0

1.0

—

6.92

—

Disorders of globe

0.00

-0.00

0.0

1.0

—

6.01

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

0.00

-0.00

0.0

1.0

—

7.67

—

Other adrenocortical overactivity

0.00

-0.00

0.0

1.0

—

5.55

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

-0.00

0.0

1.0

—

7.34

—

Contact with other and unspecified heat and hot substances

0.00

-0.00

0.0

1.0

—

5.79

—

Severe mental retardation

0.00

-0.00

0.0

1.0

—

3.73

—

Protein-energy malnutrition of moderate and mild degree

0.00

-0.00

0.0

1.0

—

5.09

—

Other factor of the environment

0.00

-0.00

0.0

1.0

—

6.01

—

Orthopaedic devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

6.37

—

Thyrotropin deficiency

0.00

-0.00

0.0

1.0

—

5.77

—

Lifestyle-related condition

0.00

-0.00

0.0

1.0

—

6.17

—

Hand

0.00

-0.00

0.0

1.0

—

6.32

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

1.0

—

11.12

—

Personal history of allergy to analgesic agent

0.00

-0.00

0.0

1.0

—

5.87

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

1.0

—

3.33

—

0.00

-0.00

0.0

1.0

—

6.48

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

0.00

-0.00

0.0

1.0

—

6.49

—

Other bursal cyst

0.00

-0.00

0.0

1.0

—

7.37

—

Congenital malformations of trachea and bronchus

0.00

-0.00

0.0

1.0

—

6.15

—

Other specified/unspecified nutritional deficiencies

0.00

-0.00

0.0

1.0

—

6.22

—

Moderate mental retardation

0.00

-0.00

0.0

1.0

—

3.93

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin in CSF/Albumin in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS